Autologous Bone Marrow Stem Cells in Ischemic Stroke.


Phase 1/2 Results N/A

Summary of Purpose

The aim of the study is to determine the safety and tolerability of an autologous CD34+ subset bone marrow stem cell infusion into the middle cerebral artery in patients who have suffered acute total or partial anterior circulation syndrome (TACS/PACS).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 February 2016.

1 Sep 2007 25 Sep 2007 1 Jul 2012 1 Dec 2012 1 Jul 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Basic Science
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


  • Jeremy Chataway, MA, BM BCH, PhD, MRCP (UK)